跳到正文
openFDA 已分级药品召回执法报告·· 19 天前AI 评分58

FDA 执法报告 D-0105-2027:Eagle Pharma Outsourcing 因无菌保证不足召回 Phenylphrine HCl 输液

FDA drug enforcement D-0105-2027: Eagle Pharma Outsourcing LLC — Lack of Assurance of Sterility

AI 导读

FDA 执法报告 D-0105-2027 收录 Eagle Pharma Outsourcing LLC 的 II 级药品召回,涉及 Phenylphrine HCl 输液(100 mg/250 mL,0.4 mg/mL),原因为无菌保证不足。

正文 · 原文

FDA drug recall enforcement report — D-0105-2027

Report issued: 2026-11-04. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "2200 Riverchase Ctr Ste 675",

"address_2": "",

"center_classification_date": "20261028",

"city": "Hoover",

"classification": "Class II",

"code_info": "Lot: PHENYL100-1004, Expiry: 12/31/2026.",

"country": "United States",

"distribution_pattern": "Nationwide within the U.S",

"event_id": "100073",

"initial_firm_notification": "E-Mail",

"more_code_info": "",

"openfda": {},

"postal_code": "35244-2918",

"product_description": "PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985210025. NDC 69852-100-25",

"product_quantity": "50 250 mL-containers",

"product_type": "Drugs",

"reason_for_recall": "Lack of Assurance of Sterility",

"recall_initiation_date": "20261008",

"recall_number": "D-0105-2027",

"recalling_firm": "Eagle Pharma Outsourcing LLC",

"report_date": "20261104",

"state": "AL",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov